Furthermore, prior studies have demonstrated that MYO1D interacts with SPAG6 and regulates the expression of the EGFR family, signaling pathways, and the advancement of acute murine leukemia (AML). This evidence concerns the gene SPAG6 and acute myeloid leukemia.